Versant Capital Management’s GeneDx Holdings WGS Stock Holding History

Versant Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.9K	Hold	455	–	–	﹤0.01%	1687
2026 Q2	$31.2K	Sell	455 -21	-4%	-$1.19K	﹤0.01%	1693
2026 Q1	$30.6K	Buy	476 +21	+5%	+$1.92K	﹤0.01%	1556
2025 Q4	$59.2K	Hold	455	–	–	0.01%	1001
2025 Q3	$49K	Hold	455	–	–	0.01%	1047
2025 Q2	$42K	Hold	455	–	–	0.01%	1077
2025 Q1	$40.3K	Hold	455	–	–	0.01%	960
2024 Q4	$35K	Hold	455	–	–	0.01%	732
2024 Q3	$19.3K	Hold	455	–	–	﹤0.01%	812
2024 Q2	$11.9K	Hold	455	–	–	﹤0.01%	915
2024 Q1	$4.15K	Hold	455	–	–	﹤0.01%	1099
2023 Q4	$1.25K	Hold	455	–	–	﹤0.01%	1441
2023 Q3	$1.66K	Hold	455	–	–	﹤0.01%	1366
2023 Q2	$2.71K	Hold	455	–	–	﹤0.01%	1263
2023 Q1	$5.48K	Buy	+455	New	+$6.07K	﹤0.01%	911
2021 Q3	–	Sell	-182	Closed	-$84K	–	1616
2021 Q2	$84K	Buy	182 +91	+100%	+$39.1K	0.03%	159
2021 Q1	$45K	Buy	+91	New	+$47.3K	0.02%	304

Other funds holding WGS

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Versant Capital Management's WGS Position: Q3 2026 in Review

Versant Capital Management held its GeneDx Holdings (WGS) position steady in Q3 2026 at 455 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Versant Capital Management first reported a position in WGS in Q1 2021 and has held it in 17 quarters since. The position peaked at $84K in Q2 2021. 83 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

Versant Capital Management held 455 shares of GeneDx Holdings worth $32.9K as of Q3 2026.
Versant Capital Management left its GeneDx Holdings share count unchanged in Q3 2026.
GeneDx Holdings made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1687 holding.
Versant Capital Management first reported a position in GeneDx Holdings in Q1 2021 and has held it in 17 quarters since.
Versant Capital Management's GeneDx Holdings position peaked at $84K in Q2 2021.
83 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.